To the Editor: It is sometimes difficult to obtain satisfactory results in in situ hybridization for mRNA using the archival formalin-fixed paraffin-embedded tissues, because RNA is easily degraded by RNase in tissues handled by routine methods. Reverse transcriptase in situ polymerase chain reaction (RT in situ PCR) 1 is a newly developed technique that allows in situ amplification of reverse-transcribed complementary DNA (cDNA) originating from mRNA. 1–3 The technique is thus considered to be more suitable for in situ detection of target mRNA in routinely processed formalin-fixed paraffin-embedded tissue sections than in situ hybridization. In a previous article in this journal, 4 we immunohistochemically examined the localization of vascular endothelial growth factor (VEGF) in sclerosing stromal tumor, a rare benign ovarian tumor histologically characterized by a unique morphology and marked vasculature. VEGF was predominantly positive in luteinized theca-like cells, a distinct component of cellular pseudolobules of sclerosing stromal tumors, and ordinary reverse transcription-polymerase chain reaction (RT-PCR) confirmed the expression of VEGF mRNA. In addition, we also detected an immunohistochemically positive endothelial cell-specific VEGF receptor in the endothelium of small to capillary-sized blood vessels of sclerosing stromal tumor. We thus concluded that the expression of VEGF in the luteinized theca-like cells of sclerosing stromal tumor was probably involved in the morphogenesis of this tumor. To confirm VEGF expression in the luteinized theca-like cells, we used the RT in situ PCR for VEGF mRNA using formalin-fixed paraffin-embedded tissue sections of sclerosing stromal tumor. RT in situ PCR was performed using the method described by Nuovo 3 with some modifications, including the addition of a hot start procedure, microwave pretreatment to retrieve the reactivity of mRNA, 5 and improvement of the visualization method. The primer sequences and reaction conditions were almost similar to those of the previous RT-PCR for VEGF mRNA, 4 and appropriate negative and positive controls were included in the experiment. The integrity of RNA in the paraffin-embedded tissues was confirmed by in situ hybridization of 28S ribosomal RNA. 6 The signals corresponding to VEGF mRNA were found predominantly in the cytoplasm of luteinized theca-like cells (Fig. 1). Nonspecific background staining was minimal. Although a degree of nuclear labeling, probably resulting from genomic DNA amplification and repair, 3 was observed, the result confirmed the expression of VEGF mRNA in the luteinized theca-like cells as well as our hypothesis concerning the morphogenesis of sclerosing stromal tumor.FIG. 1.: Labeling for amplified VEGF cDNA is observed in the cytoplasm of epithelioid cells corresponding to luteinized theca-like cells.One of the reasons why immunohistochemical staining has become universally used as a diagnostic and research tool in the field of surgical pathology is that it allows easy and reliable detection of a specific antigen using formalin-fixed, paraffin-embedded tissue sections. In the present experiment, RT in situ PCR was considered as a suitable and convenient tool for surgical pathologists to detect target mRNA with the archival formalin-fixed, paraffin-embedded tissue. However, there are a number of problems that have to be resolved before the method is widely used. These include procedural improvement of mRNA preservation in the formalin-fixed, paraffin-embedded tissues, standardization of RT in situ PCR procedure, reduction of nonspecific labeling, and inhibition of genomic DNA amplification and repair. In conclusion, RT in situ PCR on formalin-fixed, paraffin-embedded tissue sections of sclerosing stromal tumor confirmed the expression of VEGF mRNA. We think RT in situ PCR could be potentially useful for the detection of mRNA in formalin-fixed paraffin-embedded tissues. Shigeto Kawauchi M.D. Toshiro Fukuda M.D. Masazumi Tsuneyoshi M.D.
Read full abstract